Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
ACS Omega|January 1, 2024
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching ApplicationBao T Le, Suxiang Chen, Rakesh N Veedu
Biomolecules|July 27, 2024
Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO-PS Backbone for Splice-Switching ApplicationsBao T Le, Suxiang Chen, Rakesh N Veedu
RSC Advances|April 15, 2022
Evaluation of DNA segments in 2'-modified RNA sequences in designing efficient splice switching antisense oligonucleotidesBao T Le, Sudhir Agarwal, Rakesh N Veedu
ACS Omega|August 4, 2020
Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in VitroBao T Le, Tamer R Kosbar, Rakesh N Veedu
Cancer Research|June 19, 2021
CDK6 Is a Therapeutic Target in MyelofibrosisAvik Dutta, Dipmoy Nath, Yue Yang, et al.
Scientific Reports|May 11, 2017
Novel Chemically-modified DNAzyme targeting Integrin alpha-4 RNA transcript as a potential molecule to reduce inflammation in multiple sclerosisMadhuri Chakravarthy, May T Aung-Htut, Bao T Le, et al.
Chemical Communications (Cambridge, England)|October 30, 2016
Evaluation of anhydrohexitol nucleic acid, cyclohexenyl nucleic acid and d-altritol nucleic acid-modified 2'-O-methyl RNA mixmer antisense oligonucleotides for exon skipping in vitroBao T Le, Suxiang Chen, Mikhail Abramov, et al.
Scientific Reports|April 17, 2019
Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitroSuxiang Chen, Bao T Le, Madhuri Chakravarthy, et al.
Scientific Reports|April 18, 2020
Author Correction: Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitroSuxiang Chen, Bao T Le, Madhuri Chakravarthy, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Rational Design of Short Locked Nucleic Acid-Modified 2'-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In VitroBao T Le, Abbie M Adams, Susan Fletcher, et al.
Pageof 3